National Heart & Lung Institute (NHLI)

Heart Science

Head - Professor Michael Schneider

cardiacThe Heart Science Section is within the National Heart and Lung Institute's Cardiovascular Science Division: Heart Failure component. The Section is made up of four Research Units (Cardiovascular Genetics, Cell biology and Biochemistry, Molecular and Cellular Physiology/Pharmacology, Regeneration and Repair). Within the Research Units are Research Groups, each headed by a Principal Investigator.

The Section focuses on understanding the fundamental biology of heart muscle and other cell components of the myocardium under normal conditions and in disease states. A key feature of the Section is that research is directed towards understanding how the function of the constituent cells of the heart leads to the clinical manifestations of disease and how new treatments may be discovered and tested. Members of the Section are on three sites (South Kensington, Royal Brompton and Harefield) where access to human material is available. There is a strong component of translational research within the Section by which is meant the application of basic science to understanding the pathophysiology of clinical disease states in man with the intention of improving diagnosis and treatment. The major, but not the only, clinical syndrome being addressed is heart failure in all its manifestations. The breadth of the research and variety of techniques available are substantial. Research extends from research into the function of molecules to research on the growth, death and regeneration of myocytes in the intact heart in vivo and study of human material in vitro.

Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook